Restricted accessReview articleFirst published online 2025-2
A scoping review of global patterns in reporting race,ethnicity,nationality,or religion in palliative care randomized controlled trials: Recommendations for transparency
Though randomized controlled trials of non-pharmacological palliative care interventions have shown positive outcomes, findings are often generalized with limited consideration for the impact of the influence of race, ethnicity, nationality, or religion on said outcomes.
Aim:
To identify trends and gaps in global reporting of racial, ethnic, nationality, and religious demographics in non-pharmacological palliative care randomized controlled trials.
Design:
We conducted a scoping review guided by the Joanna Briggs methodology,
Data sources:
Global randomized controlled trials published in English, between 1999 and 2021 extracted from databases: Cochrane, PubMed, and Scopus. Inclusion criteria were non-pharmacological palliative care interventions for people with serious conditions reporting on one or more of the demographics of race, ethnicity, nationality, or religion.
Results:
Our review included 131 (44%) articles published from 19 countries, predominantly the USA (n = 84, 64%). Most studies focused on cancer (n = 71, 54%) in inpatient settings (n = 85, 64%). Race was the most commonly reported demographic (n = 93, 70%), followed by ethnicity (n = 54, 41%), religion (n = 46, 35%), nationality (n = 20, 15%). Within racial reporting, 86 (92%) indicating a majority White/Caucasian sample. Only 14 (10%) articles provided context connecting participant demographics to intervention outcomes. Demographic data was discussed only as a limitation to generalizability in 18 cases (41%).
Conclusions:
Improving greater transparency in study reporting of social and historical context about population demographics, including specific demographic data collected, may better identify unmet palliative needs, facilitate cross-cultural interpretation, and improve adaptation and implementation of non-pharmacological palliative care interventions.
AltmanDGMoherD. The importance of transparent reporting of health research. In: MoherDAltmanDGSchulzI, et al. (eds) Guidelines for reporting Health Research: a user’s Manual. London: Wiley Blackwell, 2014, pp.3–13.
2.
CaulleyLCatalá-LópezFWhelanJ, et al. Reporting guidelines of health research studies are frequently used inappropriately. J Clin Epidemiol2020; 122: 87–94.
3.
SigurdardottirKOldervollLHjermstadM, et al. How are palliative care cancer populations characterized in randomized controlled trials? A literature review. J Pain Symptom Manage2013; 47: 906–914.e17.
4.
PirlWFSaez-FloresESchlumbrechtM, et al. Race and ethnicity in the evidence for integrating palliative care into oncology. J Oncol Pract2018; 14: e346–e356.
5.
GonçalvesJPLucchettiGMenezesPR, et al. Religious and spiritual interventions in mental health care: a systematic review and meta-analysis of randomized controlled clinical trials. Psychol Med2015; 45: 2937–2949.
6.
BenitesACRodinGLeiteA, et al. The experience of spirituality in family caregivers of adult and elderly cancer patients receiving palliative care: a meta-synthesis. Eur J Cancer Care2021; 30: e13424.
7.
AjibadeAHookJNUtseySO, et al. Racial/ethnic identity, religious commitment, and well-being in African Americans. J Black Psychol2016; 42: 244–258.
8.
TurnerBESteinbergJRWeeksBT, et al. Race/ethnicity reporting and representation in US clinical trials: a cohort study. Lancet Reg Health Am2022; 11: 100252.
9.
SauerABDaherGSLohseCM, et al. Underreporting and underrepresentation of race and ethnicity in head and neck cancer trials, 2010–2020: a systematic review. JAMA Otolaryngol Head Neck Surg2022; 148: 662–669.
10.
EmmerichN.Leadership in palliative medicine: moral, ethical and educational. BMC Med Ethics2018; 19: 55.
11.
FlanaginAFreyTChristiansenSL.Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA2021; 326: 621–627.
12.
BorrellLNElhawaryJRFuentes-AfflickE, et al. Race and genetic ancestry in medicine – a time for reckoning with racism. N Engl J Med2021; 384: 474–480.
13.
IoannidisJPAPoweNRYancyC. Recalibrating the use of race in medical research. JAMA2021; 325: 623–624.
14.
PetersMDJMarnieCTriccoAC, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth2020; 18: 2119–2126.
15.
HannanEL.Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. JACC Cardiovasc Interv2008; 1: 211–217.
16.
KhalilHRistevskiE.The challenges of evidence-based palliative care research. Int J Evid Based Healthc2018; 16: 136–137.
17.
HallingCMBWolfRTSjøgrenP, et al. Cost-effectiveness analysis of systematic fast-track transition from oncological treatment to specialised palliative care at home for patients and their caregivers: the DOMUS trial. BMC Palliat Care2020; 19: 142.
18.
do CarmoTMPaivaBSRde OliveiraCZ, et al. The feasibility and benefit of a brief psychosocial intervention in addition to early palliative care in patients with advanced cancer to reduce depressive symptoms: a pilot randomized controlled clinical trial. BMC cancer2017; 17: 564.
19.
HallSGoddardCOpioD, et al. Feasibility, acceptability and potential effectiveness of Dignity Therapy for older people in care homes: a phase II randomized controlled trial of a brief palliative care psychotherapy. Palliat Med2012; 26: 703–712.
20.
HigginsonIJCostantiniMSilberE, et al. Evaluation of a new model of short-term palliative care for people severely affected with multiple sclerosis: a randomised fast-track trial to test timing of referral and how long the effect is maintained. Postgrad Med J2011; 87: 769–775.
21.
NgDLChaiCSTanKL, et al. The efficacy of a single session of 20-minute mindful breathing in reducing dyspnea among patients with acute decompensated heart failure: a randomized controlled trial. Am J Hosp Palliat Care2021; 38: 246–252.
22.
El AliliMSmalingHJAJolingKJ, et al. Cost-effectiveness of the Namaste care family program for nursing home residents with advanced dementia in comparison with usual care: a cluster-randomized controlled trial. BMC Health Serv Res2020; 20: 831.
23.
HenselmansIvan LaarhovenHWMvan MaarschalkerweerdP, et al. Effect of a skills training for oncologists and a patient communication aid on shared decision making about palliative systemic treatment: a randomized clinical trial. Oncologist2020; 25: e578–e588.
24.
BestMMcArdleMBHuangYJ, et al. How and how much is spirituality discussed in palliative care consultations for advanced cancer patients with and without a question prompt list?Patient Educ Couns2019; 102: 2208–2213.
25.
AuDHUdrisEMEngelbergRA, et al. A randomized trial to improve communication about end-of-life care among patients with COPD. Chest2012; 141: 726–735.
26.
HudsonPLArandaSHayman-WhiteK.A psycho-educational intervention for family caregivers of patients receiving palliative care: a randomized controlled trial. J Pain Symptom Manage2005; 30: 329–341.
27.
JuliãoMOliveiraFNunesB, et al. Effect of dignity therapy on end-of-life psychological distress in terminally ill Portuguese patients: a randomized controlled trial. Palliat Support Care2017; 15: 628–637.
28.
MalhotraCSimDJaufeerallyFR, et al. Impact of a formal advance care planning program on end-of-life care for patients with heart failure: results from a randomized controlled trial. J Card Fail2020; 26: 594–598.
29.
EychmüllerSZwahlenSFliednerMC, et al. Single early palliative care intervention added to usual oncology care for patients with advanced cancer: a randomized controlled trial (SENS Trial). Palliat Med2021; 35: 1108–1117.
30.
MaungtougNOthaganontPLiehrP.Adding ritualized chanting to the palliative care of cancer patients at the end of life: a randomized controlled trial. J Soc Work End Life Palliat Care2021; 17: 35–49.
31.
BakitasMDionne-OdomJNPamboukianSV, et al. Engaging patients and families to create a feasible clinical trial integrating palliative and heart failure care: results of the ENABLE CHF-PC pilot clinical trial. BMC Palliat Care2017; 16: 45.
32.
BakitasMADionne-OdomJNEjemDB, et al. Effect of an early palliative care telehealth intervention vs usual care on patients with heart failure: the ENABLE CHF-PC randomized clinical trial. JAMA Intern Med2020; 180: 1203–1213.
33.
LyonMECaceresSScottRK, et al. Advance care planning-complex and working: longitudinal trajectory of congruence in end-of-life treatment preferences: an RCT. Am J Hosp Palliat Care2021; 38: 634–643.
34.
ThompkinsJDNeedleJBakerJN, et al. Pediatric advance care planning and families’ positive caregiving appraisals: an RCT. Pediatrics2021; 147: e2020029330. DOI: 10.1542/peds.2020-029330.
35.
PrescottATHullJGDionne-OdomJN, et al. The role of a palliative care intervention in moderating the relationship between depression and survival among individuals with advanced cancer. Health Psychol2017; 36: 1140–1146.
36.
MilburyKLiYDurraniS, et al. A mindfulness-based intervention as a supportive care strategy for patients with metastatic non-small cell lung cancer and their spouses: results of a three-arm pilot randomized controlled trial. Oncologist2020; 25: e1794–e1802.
37.
El-JawahriALeBlancTWKavanaughA, et al. Effectiveness of integrated palliative and oncology care for patients with acute myeloid leukemia: a randomized clinical trial. JAMA Oncol2021; 7: 238–245.
38.
WellsJCSharmaSDel PaggioJC, et al. An analysis of contemporary oncology randomized clinical trials from low/middle-income vs high-income countries. JAMA Oncol2021; 7: 379–385.
39.
KhanTAbimbolaSKyobutungiC, et al. How we classify countries and people—and why it matters. BMJ Glob Health2022; 7: e009704.
40.
AlamS.Majority world: challenging the west’s rhetoric of democracy. Amerasia J2008; 34: 88–98.
41.
AlemayehuCMitchellGNiklesJ.Barriers for conducting clinical trials in developing countries- a systematic review. Int J Equity Health2018; 17: 37.
MarshallIJL’EsperanceVMarshallR, et al. State of the evidence: a survey of global disparities in clinical trials. BMJ Glob Health2021; 6: e004145.
44.
ChenEKRiffinCReidMC, et al. Why is high-quality research on palliative care so hard to do? Barriers to improved research from a survey of palliative care researchers. J Palliat Med2014; 17: 782–787.
45.
DjurisicSRathAGaberS, et al. Barriers to the conduct of randomised clinical trials within all disease areas. Trials2017; 18: 360.
46.
HamelLMPennerLAAlbrechtTL, et al. Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control2016; 23: 327–337.
47.
KadamRABordeSUMadasSA, et al. Challenges in recruitment and retention of clinical trial subjects. Perspect Clin Res2016; 7: 137–143.
48.
MarcewiczLKunihiroSKCurseenKA, et al. Application of critical race theory in palliative care research: a scoping review. J Pain Symptom Manage2022; 63: e667–e684.
RegoFGonçalvesFMoutinhoS, et al. The influence of spirituality on decision-making in palliative care outpatients: a cross-sectional study. BMC Palliat Care2020; 19: 22.
52.
SabetPKarimiSDehghanA, et al. Effect of spirituality-based palliative care on pain, nausea, vomiting, and the quality of life in women with colon cancer: a clinical trial in Southern Iran. J Relig Health2023; 62: 1985–1997.
BernalGAdamesC.Cultural adaptations: conceptual, ethical, contextual, and methodological issues for working with ethnocultural and majority-world populations. Prev Sci2017; 18: 681–688.
55.
CardemilEV.Cultural adaptations to empirically supported treatments: a research agenda. Sci Rev Mental Health Pract2010; 7: 8–21.
56.
LauASChangDFOkazakiS, et al. Psychotherapy outcome research with ethnic minorities: what is the agenda? In: Zane N, Bernal G and Leong LTL (eds) Evidence-based psychological practice with ethnic minorities: culturally informed research and clinical strategies. Washington, DC: American Psychological Association, 2016, pp.31–53.
57.
Bouça-MachadoRRosárioMAlarcãoJ, et al. Clinical trials in palliative care: a systematic review of their methodological characteristics and of the quality of their reporting. BMC Palliat Care2017; 16: 10.
58.
VisserCHadleyGWeeB.Reality of evidence-based practice in palliative care. Cancer Biol Med2015; 12: 193–200.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
